Asset Allocation
Find the right asset allocation for Best 25 Stocks
Add portfolio to the optimizer to find optimal allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio OptimizerPerformance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Best 25 Stocks, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends. The portfolio is rebalanced Every 3 months.
Loading charts...
Returns By Period
| Position | 1D | 1M | 6M | YTD | 1Y | 3Y* | 5Y* | 10Y* | ALL TIME* |
|---|---|---|---|---|---|---|---|---|---|
Benchmark S&P 500 Index | -0.19% | -0.76% | 7.25% | 8.73% | 18.21% | 17.95% | 11.30% | 13.09% | 8.08% |
Portfolio Best 25 Stocks | -0.17% | 4.19% | 6.99% | 8.57% | 10.93% | — | — | — | 38.08% |
| Portfolio components: | |||||||||
AFL Aflac Incorporated | -0.51% | 7.46% | 14.50% | 13.71% | 24.45% | 22.26% | 20.88% | 15.59% | 17.31% |
AHR American Healthcare REIT, Inc. | -0.87% | 22.39% | 19.22% | 21.63% | 53.02% | — | — | — | 90.18% |
AJG Arthur J. Gallagher & Co. | -0.09% | 18.50% | -1.25% | -1.36% | -18.08% | 6.09% | 13.67% | 19.74% | 12.61% |
BRBR BellRing Brands, Inc. | 0.25% | 28.44% | -49.18% | -54.55% | -79.12% | -30.14% | -17.42% | — | -3.63% |
BSX Boston Scientific Corporation | -0.59% | -3.36% | -50.30% | -54.10% | -57.77% | -6.27% | 0.09% | 6.23% | 7.06% |
CL Colgate-Palmolive Company | -0.56% | 3.33% | 10.74% | 18.45% | 8.51% | 8.51% | 4.73% | 4.55% | 10.30% |
CPRX Catalyst Pharmaceuticals, Inc. | 0.00% | 0.35% | 38.72% | 34.92% | 49.74% | 32.72% | 41.46% | 44.91% | 8.79% |
DRI Darden Restaurants, Inc. | -1.87% | -7.99% | -7.79% | 8.35% | -4.08% | 8.03% | 9.63% | 15.28% | 14.57% |
EXC Exelon Corporation | -0.65% | 0.33% | 4.60% | 7.34% | 9.72% | 6.88% | 11.11% | 9.47% | 8.98% |
FICO Fair Isaac Corporation | 0.53% | 15.26% | -19.36% | -25.24% | -18.02% | 14.38% | 18.50% | 26.66% | 20.55% |
Monthly Returns
Based on dividend-adjusted daily data since Mar 27, 2024, Best 25 Stocks's average daily return is +0.13%, while the average monthly return is +2.69%. At this rate, an investment would double in approximately 2.2 years.
Historically, 69% of months were positive and 31% were negative. The best month was Nov 2024 with a return of +13.1%, while the worst month was Dec 2024 at -5.1%. The longest winning streak lasted 7 consecutive months, and the longest losing streak was 2 months.
On a daily basis, Best 25 Stocks closed higher 57% of trading days. The best single day was Apr 9, 2025 with a return of +6.6%, while the worst single day was Apr 4, 2025 at -6.6%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 1.56% | 8.42% | -4.52% | 1.65% | -0.76% | -0.18% | 2.56% | 8.57% | |||||
| 2025 | 7.22% | 6.24% | -0.67% | 5.09% | 3.60% | 1.83% | -0.42% | 1.15% | 1.50% | -0.49% | 2.05% | -2.59% | 26.88% |
| 2024 | 1.79% | -1.77% | 7.33% | 2.37% | 7.96% | 9.01% | 6.14% | 3.99% | 13.10% | -5.13% | 53.13% |
Benchmark Metrics
Best 25 Stocks has an annualized alpha of 25.97%, beta of 0.62, and R2 of 0.49 versus S&P 500 Index. Calculated based on daily prices since March 27, 2024.
- This portfolio captured 109.40% of S&P 500 Index gains and tended to rise during its downturns (downside capture of -52.48%) - a profile typical of hedging or uncorrelated assets.
- Beta of 0.62 may look defensive, but with R2 of 0.49 this portfolio is largely uncorrelated with S&P 500 Index - low beta reflects independence, not downside protection. See the Volatility section for a true picture of this portfolio's risk.
- R2 of 0.49 means the benchmark explains less than half of this portfolio's behavior - treat beta with caution or consider switching to a more representative benchmark.
- Alpha
- 25.97%
- Beta
- 0.62
- R²
- 0.49
- Upside Capture
- 109.40%
- Downside Capture
- -52.48%
Expense Ratio
Best 25 Stocks has an expense ratio of 0.00%, meaning no management fees are charged. Below, you can find the expense ratios of the portfolio's funds side by side and easily compare their relative costs.
Return for Risk
Risk / Return Rank
Best 25 Stocks ranks 22 for risk / return — below 22% of Portfolios on our site. The returns aren't fully compensating for the risk involved. This isn't necessarily a dealbreaker, but factor it into your decision — especially if you're risk-averse.
Return / Risk — by metrics
The table below presents risk-adjusted performance metrics for Best 25 Stocks and compares them with S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| Portfolio | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | 1.07 | 1.45 | -0.38 |
| Sortino ratioReturn per unit of downside risk | 1.64 | 2.03 | -0.38 |
| Omega ratioGain probability vs. loss probability | 1.18 | 1.26 | -0.08 |
| Calmar ratioReturn relative to maximum drawdown | 1.72 | 2.01 | -0.29 |
| Martin ratioReturn relative to average drawdown | 4.05 | 8.68 | -4.63 |
How much return does each position deliver for the risk it carries? Higher values mean better reward for the risk taken.
| Position | Risk / Return Rank | Sharpe ratio | Sortino ratio | Omega ratio | Calmar ratio | Martin ratio |
|---|---|---|---|---|---|---|
AFL Aflac Incorporated | 83 | 1.44 | 2.10 | 1.25 | 2.69 | 7.07 |
AHR American Healthcare REIT, Inc. | 91 | 2.17 | 2.81 | 1.37 | 3.91 | 10.27 |
AJG Arthur J. Gallagher & Co. | 23 | -0.61 | -0.69 | 0.91 | -0.47 | -0.79 |
BRBR BellRing Brands, Inc. | 6 | -1.04 | -1.87 | 0.71 | -0.92 | -1.32 |
BSX Boston Scientific Corporation | 2 | -1.62 | -2.59 | 0.64 | -0.96 | -1.81 |
CL Colgate-Palmolive Company | 56 | 0.38 | 0.71 | 1.08 | 0.50 | 0.90 |
CPRX Catalyst Pharmaceuticals, Inc. | 87 | 1.54 | 2.14 | 1.31 | 3.52 | 9.42 |
DRI Darden Restaurants, Inc. | 36 | -0.16 | -0.04 | 0.99 | -0.20 | -0.44 |
EXC Exelon Corporation | 60 | 0.51 | 0.87 | 1.10 | 0.71 | 1.63 |
FICO Fair Isaac Corporation | 31 | -0.36 | -0.20 | 0.97 | -0.36 | -0.68 |
Loading charts...
Dividends
Dividend yield
Best 25 Stocks provided a 1.57% dividend yield over the last twelve months.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Portfolio | 1.57% | 1.64% | 2.53% | 1.87% | 1.67% | 1.52% | 1.75% | 1.52% | 1.70% | 1.43% | 3.49% | 1.60% |
| Portfolio components: | ||||||||||||
AFL Aflac Incorporated | 1.92% | 2.10% | 1.93% | 2.04% | 2.22% | 2.26% | 2.52% | 2.04% | 2.28% | 1.98% | 2.39% | 2.64% |
AHR American Healthcare REIT, Inc. | 1.76% | 2.12% | 3.52% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
AJG Arthur J. Gallagher & Co. | 1.06% | 1.00% | 0.85% | 0.98% | 1.08% | 1.13% | 1.46% | 1.81% | 2.23% | 2.47% | 2.93% | 3.62% |
BRBR BellRing Brands, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
BSX Boston Scientific Corporation | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
CL Colgate-Palmolive Company | 2.28% | 2.61% | 2.18% | 2.40% | 2.36% | 2.10% | 2.05% | 2.48% | 2.79% | 2.11% | 2.37% | 2.25% |
CPRX Catalyst Pharmaceuticals, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
DRI Darden Restaurants, Inc. | 3.14% | 3.15% | 2.90% | 3.07% | 3.34% | 2.29% | 0.99% | 2.99% | 2.76% | 2.48% | 2.92% | 13.76% |
EXC Exelon Corporation | 3.57% | 3.67% | 5.05% | 4.01% | 3.12% | 2.65% | 3.62% | 3.18% | 3.06% | 3.32% | 3.56% | 4.47% |
FICO Fair Isaac Corporation | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.01% | 0.07% | 0.08% |
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Best 25 Stocks. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Best 25 Stocks was 9.66%, occurring on Apr 8, 2025. Recovery took 10 trading sessions.
The current Best 25 Stocks drawdown is 1.85%.
Drawdown | Fall | Recovery | Underwater | Related event |
|---|---|---|---|---|
-9.66%Apr 2025 | 1mo 18d | 15d | 2mo 3dFeb 2025 - Apr 2025 | 2025 selloff2025 |
-6.62%Dec 2024 | 19d | 1mo 4d | 1mo 23dNov 2024 - Jan 2025 | — |
-6.37%Jun 2026 | 3mo 19d | — | 4mo 18dMar 2026 - now | — |
-4.13%Apr 2024 | 15d | 17d | 1mo 2dApr 2024 - May 2024 | — |
-3.50%Jan 2026 | 1mo 26d | 1mo | 2mo 26dNov 2025 - Feb 2026 | — |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Diversification
Diversification Metrics
Number of Effective Assets
The portfolio contains 32 assets, with an effective number of assets of 20.00, reflecting the diversification based on asset allocation. Your allocation shows noticeable concentration: a few holdings carry significantly more weight than the rest. Rebalancing toward more even weights — or adding less correlated assets — could reduce risk.
Diversification Ratio
1Y | All Time | |
|---|---|---|
Diversification Ratio | 3.00 | 2.23 |
The portfolio has a diversification ratio of 2.23, placing it in the top 5% across portfolios — assets in this portfolio move largely independently, providing strong diversification benefit.
Best 25 Stocks correlation to the S&P 500 Index
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.40 |
Correlation (All Time) Calculated using the full available price history since Mar 27, 2024 | 0.57 |
Benchmark Correlations
Correlation vs. S&P 500 Index. GEV has the highest benchmark correlation at 0.54, while MO has the lowest at -0.13.
Asset Correlations Table
Find what Best 25 Stocks is missing
See which holdings overlap, where Best 25 Stocks is concentrated, and which low-correlation assets could fill the gaps.
Analyze Diversification